Creative Medical Technology Holdings, Inc. cash flow to debt ratio of -41.26K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Creative Medical Technology Holdings, Inc.'s free cash flow has decreased 10.47% from $-5.30M last year to $-5.86M, signaling decreasing performance

Creative Medical Technology Holdings, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Creative Medical Technology Holdings, Inc. has insufficient data to evaluate this check.

Creative Medical Technology Holdings, Inc. has a net cash position, so leverage is healthy.

Creative Medical Technology Holdings, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Creative Medical Technology Holdings, Inc.'s profit margin has decreased (303.19%) in the last year from -49.94K% to -201.36K%, signaling decreasing performance

Creative Medical Technology Holdings, Inc.'s short-term assets of $7.40M exceed its short-term liabilities of $284.88K

Creative Medical Technology Holdings, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Creative Medical Technology Holdings, Inc.'s return on equity of -86.70%, is lower than 15.00%, indicating bad performance

Creative Medical Technology Holdings, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Creative Medical Technology Holdings, Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Creative Medical Technology Holdings, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Creative Medical Technology Holdings, Inc. has negative free cash flow, indicating cash burn

Creative Medical Technology Holdings, Inc.'s yearly earnings has decreased 9.13% since last year from $-5.49M to $-6.00M, signaling decreasing performance

Creative Medical Technology Holdings, Inc.'s yearly revenue has decreased 45.45% since last year from $11.00K to $6.00K, signaling decreasing performance

ROIC -53.90% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Creative Medical Technology Holdings, Inc.'s 3-year revenue CAGR of -59.24% is negative, indicating declining revenue over the past 3 years

Creative Medical Technology Holdings, Inc. had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

Creative Medical Technology Holdings, Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Creative Medical Technology Holdings, Inc. has insufficient data to evaluate this check.

Creative Medical Technology Holdings, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Creative Medical Technology Holdings, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Creative Medical Technology Holdings, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Creative Medical Technology Holdings, Inc. has insufficient data to evaluate this check.

Creative Medical Technology Holdings, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Creative Medical Technology Holdings, Inc. has a price-to-book ratio of 0.51x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Creative Medical Technology Holdings, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue